nach oben

Erschienen in:

02.05.2023 | Original Paper

Impact of the COVID-19 pandemic on cancer patients in western Pennsylvania: rural–urban disparities

verfasst von: Kathryn Demanelis, Margaret Rosenzweig, Linda B. Robertson, Carissa A. Low, Shayla Daniels, Hiba Abujaradeh, Beth Simon, Dana H. Bovbjerg, Brenda Diergaarde

Erschienen in: Cancer Causes & Control | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Disparities in cancer care persist between patients living in rural versus urban areas. The COVID-19 pandemic may have impacted concerns related to care and personal health differently in rural cancer patients. Using survey data collected from cancer patients in western Pennsylvania, we examined pandemic-related distress, concerns related to cancer care, impact on personal health, and the extent to which these differed by urban–rural residence.

Methods

Patients filled out an initial survey in August–December 2020; a second survey was completed in March 2021. The following patient concerns related to the pandemic were evaluated: threat of COVID-19 to their health, pandemic-related distress, perceptions of cancer care, and vaccine hesitancy. Multivariable logistic regression models were used to examine relationships between these outcomes and urban–rural residence as well as patient-related factors, including anxiety symptoms and social support.

Results

The study sample included 1,980 patients, 17% resided in rural areas. COVID-19 represented a major or catastrophic threat to personal health for 39.7% of rural and 49.0% of urban patients (p = 0.0017). Patients with high general anxiety were 10-times more likely to experience pandemic-related distress (p < 0.001). In the follow-up survey (n = 983), vaccine hesitancy was twice as prevalent among rural patients compared to urban (p = 0.012).

Conclusions

The extent to which perceptions of the threat of COVD-19 to personal health and vaccine hesitancy exacerbates rural–urban disparities in cancer care and prognosis warrants further study. Cancer patients may be vulnerable to heightened anxiety and distress triggered by the pandemic.

Nur mit Berechtigung zugänglich

Richards M, Anderson M, Carter P, Ebert BL, Mossialos E (2020) The impact of the COVID-19 pandemic on cancer care. Nat Cancer 1:565–567. https://doi.org/10.1038/s43018-020-0074-yCrossRefPubMedPubMedCentral

Cuadros DF, Branscum AJ, Mukandavire Z, Miller FD, MacKinnon N (2021) Dynamics of the COVID-19 epidemic in urban and rural areas in the United States. Ann Epidemiol 59:16–20. https://doi.org/10.1016/j.annepidem.2021.04.007CrossRefPubMedPubMedCentral

Andrews MR, Tamura K, Best JN, Ceasar JN, Batey KG, Kearse TA, Allen LV, Baumer Y, Collins BS, Mitchell VM et al (2021) Spatial clustering of county-level COVID-19 rates in the U.S. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph182212170CrossRefPubMedPubMedCentral

Li D, Gaynor SM, Quick C, Chen JT, Stephenson BJK, Coull BA, Lin X (2021) Identifying US County-level characteristics associated with high COVID-19 burden. BMC Public Health 21:1007. https://doi.org/10.1186/s12889-021-11060-9CrossRefPubMedPubMedCentral

Li Z, Lewis B, Berney K, Hallisey E, Williams AM, Whiteman A, Rivera-González LO, Clarke KEN, Clayton H, Tincher T et al (2022) Social vulnerability and rurality associated with higher SARS-CoV-2 infection-induced seroprevalence: a nationwide blood donor study, United States, July 2020–June 2021. Clin Infect Dis. https://doi.org/10.1093/cid/ciac105CrossRefPubMedPubMedCentral

Peters DJ (2020) Community susceptibility and resiliency to COVID-19 across the rural-urban continuum in the United States. J Rural Health 36:446–456. https://doi.org/10.1111/jrh.12477CrossRefPubMedPubMedCentral

Islam JY, Vidot DC, Camacho-Rivera M (2021) Determinants of COVID-19 preventive behaviours among adults with chronic diseases in the USA: an analysis of the nationally representative COVID-19 impact survey. BMJ Open 11:e044600. https://doi.org/10.1136/bmjopen-2020-044600CrossRefPubMed

King WC, Rubinstein M, Reinhart A, Mejia R (2021) Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: a massive online survey of US adults from January-May 2021. PLoS ONE 16:e0260731. https://doi.org/10.1371/journal.pone.0260731CrossRefPubMedPubMedCentral

Zahnd WE, James AS, Jenkins WD, Izadi SR, Fogleman AJ, Steward DE, Colditz GA, Brard L (2018) Rural-urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomarkers Prev 27:1265–1274. https://doi.org/10.1158/1055-9965.EPI-17-0430CrossRefPubMed

10.

Shete S, Deng Y, Shannon J, Faseru B, Middleton D, Iachan R, Bernardo B, Balkrishnan R, Kim SJ, Huang B et al (2021) Differences in breast and colorectal cancer screening adherence among women residing in urban and rural communities in the United States. JAMA Netw Open 4:e2128000. https://doi.org/10.1001/jamanetworkopen.2021.28000CrossRefPubMedPubMedCentral

11.

Odahowski CL, Zahnd WE, Eberth JM (2019) Challenges and opportunities for lung cancer screening in rural America. J Am Coll Radiol 16:590–595. https://doi.org/10.1016/j.jacr.2019.01.001CrossRefPubMed

12.

Moss JL, Wang M, Liang M, Kameni A, Stoltzfus KC, Onega T (2021) County-level characteristics associated with incidence, late-stage incidence, and mortality from screenable cancers. Cancer Epidemiol 75:102033. https://doi.org/10.1016/j.canep.2021.102033CrossRefPubMedPubMedCentral

13.

Sprague BL, Ahern TP, Herschorn SD, Sowden M, Weaver DL, Wood ME (2021) Identifying key barriers to effective breast cancer control in rural settings. Prev Med 152:106741. https://doi.org/10.1016/j.ypmed.2021.106741CrossRefPubMedPubMedCentral

14.

Yao N, Alcalá HE, Anderson R, Balkrishnan R (2017) Cancer disparities in rural Appalachia: incidence, early detection, and survivorship. J Rural Health 33:375–381. https://doi.org/10.1111/jrh.12213CrossRefPubMed

15.

Eberth JM, Zahnd WE, Adams SA, Friedman DB, Wheeler SB, Hébert JR (2019) Mortality-to-incidence ratios by US Congressional District: implications for epidemiologic, dissemination and implementation research, and public health policy. Prev Med 129s:105849. https://doi.org/10.1016/j.ypmed.2019.105849CrossRefPubMed

16.

Rogers CR, Blackburn BE, Huntington M, Curtin K, Thorpe RJ, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A et al (2020) Rural-urban disparities in colorectal cancer survival and risk among men in Utah: a statewide population-based study. Cancer Causes Control 31:241–253. https://doi.org/10.1007/s10552-020-01268-2CrossRefPubMedPubMedCentral

17.

Elkrief A, Wu JT, Jani C, Enriquez KT, Glover M, Shah MR, Shaikh HG, Beeghly-Fadiel A, French B, Jhawar SR et al (2022) Learning through a pandemic: the current state of knowledge on COVID-19 and cancer. Cancer Discov 12:303–330. https://doi.org/10.1158/2159-8290.CD-21-1368CrossRefPubMed

18.

Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q et al (2020) Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 10:783–791. https://doi.org/10.1158/2159-8290.CD-20-0422CrossRefPubMedPubMedCentral

19.

Wang Q, Berger NA, Xu R (2021) Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol 7:220–227. https://doi.org/10.1001/jamaoncol.2020.6178CrossRefPubMed

20.

Elkrief A, Desilets A, Papneja N, Cvetkovic L, Groleau C, Lakehal YA, Shbat L, Richard C, Malo J, Belkaid W et al (2020) High mortality among hospital-acquired COVID-19 infection in patients with cancer: a multicentre observational cohort study. Eur J Cancer 139:181–187. https://doi.org/10.1016/j.ejca.2020.08.017CrossRefPubMedPubMedCentral

21.

Chavez-MacGregor M, Lei X, Zhao H, Scheet P, Giordano SH (2022) Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer. JAMA Oncol 8:69–78. https://doi.org/10.1001/jamaoncol.2021.5148CrossRefPubMed

22.

Schmidt AL, Bakouny Z, Bhalla S, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F et al (2020) Cancer care disparities during the COVID-19 pandemic: COVID-19 and cancer outcomes study. Cancer Cell 38:769–770. https://doi.org/10.1016/j.ccell.2020.10.023CrossRefPubMedPubMedCentral

23.

Papautsky EL, Hamlish T (2020) Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Res Treat 184:249–254. https://doi.org/10.1007/s10549-020-05828-7CrossRefPubMedPubMedCentral

24.

Islam JY, Camacho-Rivera M, Vidot DC (2020) Examining COVID-19 preventive behaviors among cancer survivors in the United States: an analysis of the COVID-19 impact survey. Cancer Epidemiol Biomarkers Prev 29:2583–2590. https://doi.org/10.1158/1055-9965.EPI-20-0801CrossRefPubMedPubMedCentral

25.

Ayubi E, Bashirian S, Khazaei S (2021) Depression and anxiety among patients with cancer during COVID-19 pandemic: a systematic review and meta-analysis. J Gastrointest Cancer 52:499–507. https://doi.org/10.1007/s12029-021-00643-9CrossRefPubMedPubMedCentral

26.

Obispo-Portero B, Cruz-Castellanos P, Jiménez-Fonseca P, Rogado J, Hernandez R, Castillo-Trujillo OA, Asensio-Martínez E, González-Moya M, Carmona-Bayonas A, Calderon C (2022) Anxiety and depression in patients with advanced cancer during the COVID-19 pandemic. Support Care Cancer 30:3363–3370. https://doi.org/10.1007/s00520-021-06789-3CrossRefPubMedPubMedCentral

27.

van de Poll-Franse LV, de Rooij BH, Horevoorts NJE, May AM, Vink GR, Koopman M, van Laarhoven HWM, Besselink MG, Oerlemans S, Husson O et al (2021) Perceived care and well-being of patients with cancer and matched norm participants in the COVID-19 crisis: results of a survey of participants in the Dutch PROFILES registry. JAMA Oncol 7:279–284. https://doi.org/10.1001/jamaoncol.2020.6093CrossRefPubMed

28.

Kassianos AP, Georgiou A, Kyprianidou M, Lamnisos D, Ļubenko J, Presti G, Squatrito V, Constantinou M, Nicolaou C, Papacostas S et al (2021) Mental health and adherence to COVID-19 protective behaviors among cancer patients during the COVID-19 pandemic an international multinational cross-sectional study. Cancers (Basel). https://doi.org/10.3390/cancers13246294CrossRefPubMed

29.

Pitman A, Suleman S, Hyde N, Hodgkiss A (2018) Depression and anxiety in patients with cancer. BMJ 361:k1415. https://doi.org/10.1136/bmj.k1415CrossRefPubMed

30.

Trudel-Fitzgerald C, Tworoger SS, Zhang X, Giovannucci EL, Meyerhardt JA, Kubzansky LD (2020) Anxiety, depression, and colorectal cancer survival: results from two prospective cohorts. J Clin Med. https://doi.org/10.3390/jcm9103174CrossRefPubMedPubMedCentral

31.

Bovbjerg DH, Manculich J, Shelby RA (2022) The importance of the person/patient/survivor’s lived experience across the cancer control continuum. Cancer 128:34–38. https://doi.org/10.1002/cncr.33878CrossRefPubMed

32.

Wang YH, Li JQ, Shi JF, Que JY, Liu JJ, Lappin JM, Leung J, Ravindran AV, Chen WQ, Qiao YL et al (2020) Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry 25:1487–1499. https://doi.org/10.1038/s41380-019-0595-xCrossRefPubMed

33.

Yildirim OA, Poyraz K, Erdur E (2021) Depression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delays. Qual Life Res 30:1903–1912. https://doi.org/10.1007/s11136-021-02795-4CrossRefPubMedPubMedCentral

34.

Morales DA, Barksdale CL, Beckel-Mitchener AC (2020) A call to action to address rural mental health disparities. J Clin Transl Sci 4:463–467. https://doi.org/10.1017/cts.2020.42CrossRefPubMedPubMedCentral

35.

Kozhimannil KB, Henning-Smith C (2021) Improving health among rural residents in the US. JAMA 325:1033–1034. https://doi.org/10.1001/jama.2020.26372CrossRefPubMed

36.

Vanaken L, Scheveneels S, Belmans E, Hermans D (2020) Validation of the impact of event scale with modifications for COVID-19 (IES-COVID19). Front Psych 11:738. https://doi.org/10.3389/fpsyt.2020.00738CrossRef

37.

Spitzer RL, Kroenke K, Williams JB, Löwe B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092–1097. https://doi.org/10.1001/archinte.166.10.1092CrossRefPubMed

38.

Moser A, Stuck AE, Silliman RA, Ganz PA, Clough-Gorr KM (2012) The eight-item modified medical outcomes study social support survey: psychometric evaluation showed excellent performance. J Clin Epidemiol 65:1107–1116. https://doi.org/10.1016/j.jclinepi.2012.04.007CrossRefPubMedPubMedCentral

39.

Armitage CJ, Dawes P, Munro KJ (2022) Prevalence and correlates of COVID-19-related traumatic stress symptoms among older adults: a national survey. J Psychiatr Res 147:190–193. https://doi.org/10.1016/j.jpsychires.2021.12.054CrossRefPubMed

40.

Creamer M, Bell R, Failla S (2003) Psychometric properties of the impact of event scale—revised. Behav Res Ther 41:1489–1496. https://doi.org/10.1016/j.brat.2003.07.010CrossRefPubMed

41.

Lanzoni L, Brivio E, Oliveri S, Guiddi P, Chichua M, Mazzocco K, Pravettoni G (2022) The burden of the pain: adverse mental health outcomes of COVID-19 in women with and without cancer. Front Psychol 13:772128. https://doi.org/10.3389/fpsyg.2022.772128CrossRefPubMedPubMedCentral

42.

Yang S, Wang J, Xu X (2022) Psychological health status among thyroid cancer patients during the COVID-19 epidemic in China. Support Care Cancer 30:2111–2119. https://doi.org/10.1007/s00520-021-06624-9CrossRefPubMed

43.

Joly F, Rigal O, Guittet L, Lefèvre-Arbogast S, Grellard JM, Binarelli G, Lange M, Rieux C, Fernette M, Tron L et al (2021) Post-traumatic stress symptomatology and adjustment of medical oncology practice during the COVID-19 pandemic among adult patients with cancer in a day care hospital. Cancer 127:4636–4645. https://doi.org/10.1002/cncr.33856CrossRefPubMed

44.

Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Hammer MJ, Kenfield SA et al (2020) Stress and symptom burden in oncology patients during the COVID-19 pandemic. J Pain Symptom Manage 60:e25–e34. https://doi.org/10.1016/j.jpainsymman.2020.08.037CrossRefPubMedPubMedCentral

45.

Caston NE, Lawhon VM, Smith KL, Gallagher K, Angove R, Anderson E, Balch A, Azuero A, Huang CS, Rocque GB (2021) Examining the association among fear of COVID-19, psychological distress, and delays in cancer care. Cancer Med 10:8854–8865. https://doi.org/10.1002/cam4.4391CrossRefPubMedPubMedCentral

46.

Tsai R, Hervey J, Hoffman K, Wood J, Johnson J, Deighton D, Clermont D, Loew B, Goldberg SL (2022) COVID-19 vaccine hesitancy and acceptance among individuals with cancer, autoimmune diseases, or other serious comorbid conditions: cross-sectional internet-based survey. JMIR Public Health Surveill 8:e29872. https://doi.org/10.2196/29872CrossRefPubMedPubMedCentral

47.

Nguyen M, Bain N, Grech L, Choi T, Harris S, Chau H, Freeman D, Kwok A, Williams J, McCartney A et al (2022) COVID-19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: a multicenter study. Asia Pac J Clin Oncol. https://doi.org/10.1111/ajco.13754CrossRefPubMed

48.

Villarreal-Garza C, Vaca-Cartagena BF, Becerril-Gaitan A, Ferrigno AS, Mesa-Chavez F, Platas A (2021) Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer. JAMA Oncol 7:1242–1244. https://doi.org/10.1001/jamaoncol.2021.1962CrossRefPubMedPubMedCentral

49.

Shih SF, Wagner AL, Masters NB, Prosser LA, Lu Y, Zikmund-Fisher BJ (2021) Vaccine hesitancy and rejection of a vaccine for the novel coronavirus in the United States. Front Immunol 12:558270. https://doi.org/10.3389/fimmu.2021.558270CrossRefPubMedPubMedCentral

50.

Murthy BP, Sterrett N, Weller D, Zell E, Reynolds L, Toblin RL, Murthy N, Kriss J, Rose C, Cadwell B et al (2021) Disparities in COVID-19 vaccination coverage between Urban and Rural Counties - United States, December 14, 2020-April 10, 2021. MMWR Morb Mortal Wkly Rep 70:759–764. https://doi.org/10.15585/mmwr.mm7020e3CrossRefPubMedPubMedCentral

Titel: Impact of the COVID-19 pandemic on cancer patients in western Pennsylvania: rural–urban disparities
verfasst von: Kathryn Demanelis
Margaret Rosenzweig
Linda B. Robertson
Carissa A. Low
Shayla Daniels
Hiba Abujaradeh
Beth Simon
Dana H. Bovbjerg
Brenda Diergaarde
Publikationsdatum: 02.05.2023
Verlag: Springer International Publishing
Erschienen in: Cancer Causes & Control / Ausgabe 7/2023
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-023-01696-w

“Did I get into the twilight zone somehow?”: sexual and gender minority cancer caregiver experiences during COVID

Brief Report

Scientific uncertainty and perceived mammography benefits in women screened for breast cancer

Original Paper

Evaluating changes to home bowel cancer screening kits: an end-user perspective study

Open Access
Original Paper

Breast Cancer Champions: a peer-to-peer education and mobile mammography program improving breast cancer screening rates for women of African heritage

Original Paper

Lessons learned in the practice of community-based participatory research with community partner collaboration in study design and implementation: the community scientist model

Original Paper

The association between red, processed and white meat consumption and risk of pancreatic cancer: a meta-analysis of prospective cohort studies

Original Paper

Neu im Fachgebiet Onkologie

Polypen bei nahen Verwandten – erhöhtes Darmkrebsrisiko

20.01.2025
Risikofaktoren für Krebserkrankungen
Nachrichten

Werden bei erstgradigen Verwandten gutartige Darmpolypen identifiziert, ist das Risiko, selbst an einem Kolorektalkarzinom zu erkranken, deutlich erhöht – vor allem das für eine früh beginnende Erkrankung. Hier könnte sich eine frühe Koloskopie besonders lohnen.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

16.01.2025
Künstliche Intelligenz im Gesundheitswesen
Nachrichten

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Welche Krebserkrankungen bei Zöliakie häufiger auftreten

16.01.2025
Zöliakie
Nachrichten

Eine große Kohortenstudie hat den Zusammenhang zwischen Zöliakie und gastrointestinalen Krebserkrankungen und inflammatorischen Krankheiten untersucht. Neben gastrointestinalen Tumoren ist auch ein nicht solider Krebs häufiger.

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

15.01.2025
Urothelkarzinom
Nachrichten

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Impact of the COVID-19 pandemic on cancer patients in western Pennsylvania: rural–urban disparities